Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
WITHDRAWN: Characterization of Patterns of Immune Cell Infiltration in NSCLC.
Backman M, La Fleur L, Kurppa P, Djureinovic D, Elfving H, Brunnström H, Mattsson JSM, Pontén V, Eltahir M, Mangsbo S, Isaksson J, Jirström K, Kärre K, Carbone E, Leandersson K, Mezheyeuski A, Pontén F, Lindskog C, Botling J, Micke P. Backman M, et al. J Thorac Oncol. 2020 Feb 4:S1556-0864(20)30015-0. doi: 10.1016/j.jtho.2019.12.127. Online ahead of print. J Thorac Oncol. 2020. PMID: 32028050
ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma.
Miyashita N, Horie M, Mikami Y, Urushiyama H, Fukuda K, Miyakawa K, Matsuzaki H, Makita K, Morishita Y, Harada H, Backman M, Lindskog C, Brunnström H, Micke P, Nagase T, Saito A. Miyashita N, et al. Among authors: backman m. Cancer Lett. 2020 Oct 1;489:121-132. doi: 10.1016/j.canlet.2020.06.002. Epub 2020 Jun 10. Cancer Lett. 2020. PMID: 32534174
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer.
Elfving H, Broström E, Moens LNJ, Almlöf J, Cerjan D, Lauter G, Nord H, Mattsson JSM, Ullenhag GJ, Strell C, Backman M, La Fleur L, Brunnström H, Botling J, Micke P. Elfving H, et al. Among authors: backman m. Lung Cancer. 2021 Jan;151:53-59. doi: 10.1016/j.lungcan.2020.11.023. Epub 2020 Nov 27. Lung Cancer. 2021. PMID: 33310622
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung.
Goldmann T, Marwitz S, Nitschkowski D, Krupar R, Backman M, Elfving H, Thurfjell V, Lindberg A, Brunnström H, La Fleur L, Mezheyeuski A, Mattsson JSM, Botling J, Micke P, Strell C. Goldmann T, et al. Among authors: backman m. Cancer Immunol Immunother. 2021 Sep;70(9):2577-2587. doi: 10.1007/s00262-020-02825-z. Epub 2021 Feb 12. Cancer Immunol Immunother. 2021. PMID: 33576873 Free PMC article.
The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types.
Micke P, Strell C, Mattsson J, Martín-Bernabé A, Brunnström H, Huvila J, Sund M, Wärnberg F, Ponten F, Glimelius B, Hrynchyk I, Mauchanski S, Khelashvili S, Garcia-Vicién G, Molleví DG, Edqvist PH, O Reilly A, Corvigno S, Dahlstrand H, Botling J, Segersten U, Krzyzanowska A, Bjartell A, Elebro J, Heby M, Lundgren S, Hedner C, Borg D, Brändstedt J, Sartor H, Malmström PU, Johansson M, Nodin B, Backman M, Lindskog C, Jirström K, Mezheyeuski A. Micke P, et al. Among authors: backman m. EBioMedicine. 2021 Mar;65:103269. doi: 10.1016/j.ebiom.2021.103269. Epub 2021 Mar 9. EBioMedicine. 2021. PMID: 33706249 Free PMC article.
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response.
Bogatyrova O, Mattsson JSM, Ross EM, Sanderson MP, Backman M, Botling J, Brunnström H, Kurppa P, La Fleur L, Strell C, Wilm C, Zimmermann A, Esdar C, Micke P. Bogatyrova O, et al. Among authors: backman m. Eur J Cancer. 2021 Jul;151:136-149. doi: 10.1016/j.ejca.2021.04.005. Epub 2021 May 10. Eur J Cancer. 2021. PMID: 33984662 Free article.
125 results